CDC42 and diabetic kidney disease: Mechanistic studies revealed that miRNA-25 exerted its protective role in DKD mainly through targeting inhibition of cell division cycle 42 (CDC42) expression, a downstream effector of Ras that can lead to congenital nephrotic syndrome and glomerulosclerosis.